• 1. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 2. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 3. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

Comprehensive Overview of tert-butyl 2-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine-1-carboxylate (CAS No. 811439-53-9)

The compound tert-butyl 2-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine-1-carboxylate (CAS No. 811439-53-9) is a highly specialized boronic ester derivative with significant applications in organic synthesis and pharmaceutical research. Its unique structure, featuring a tetrahydropyridine core and a dioxaborolane moiety, makes it a valuable intermediate in the construction of complex molecules. This compound is particularly relevant in the context of Suzuki-Miyaura cross-coupling reactions, a widely used method for forming carbon-carbon bonds in drug discovery and material science.

In recent years, the demand for boron-containing compounds like tert-butyl 2-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine-1-carboxylate has surged due to their versatility in medicinal chemistry. Researchers are increasingly exploring its potential in the development of targeted therapies and bioconjugation strategies. The compound's stability under physiological conditions and its ability to participate in click chemistry reactions have made it a subject of interest in proteolysis-targeting chimeras (PROTACs) and antibody-drug conjugates (ADCs), which are among the hottest topics in modern drug development.

From a synthetic perspective, the tert-butyl carbamate (Boc) protecting group in this molecule offers excellent stability during multi-step reactions, while the tetramethyl-1,3,2-dioxaborolane unit enhances its solubility in organic solvents. This combination of features addresses common challenges in peptide synthesis and small molecule drug design, where both protection and functionalization are critical. The compound's CAS No. 811439-53-9 serves as a unique identifier in chemical databases, facilitating its tracking in high-throughput screening and combinatorial chemistry workflows.

The growing interest in sustainable chemistry has also brought attention to compounds like tert-butyl 2-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine-1-carboxylate. Its potential for atom-economical transformations aligns with the principles of green chemistry, reducing waste in pharmaceutical manufacturing. Moreover, the compound's compatibility with flow chemistry systems makes it attractive for continuous processing, a trend gaining momentum in industrial-scale synthesis.

Analytical characterization of this compound typically involves advanced techniques such as nuclear magnetic resonance (NMR) spectroscopy, high-performance liquid chromatography (HPLC), and mass spectrometry. The presence of both nitrogen and boron atoms in its structure creates unique spectroscopic signatures that aid in quality control. These analytical aspects are crucial for researchers searching for "how to characterize boron-containing compounds" or "NMR analysis of dioxaborolane derivatives" – common queries in chemical forums and search engines.

In the context of drug discovery, the tetrahydropyridine scaffold present in this compound is particularly noteworthy. This structural motif appears in numerous bioactive molecules and pharmaceuticals, explaining why searches for "tetrahydropyridine derivatives in medicinal chemistry" yield thousands of results. The incorporation of the dioxaborolane group further enhances the compound's utility, as boron-containing drugs have shown promise in treating various conditions, from inflammation to cancer.

Storage and handling of tert-butyl 2-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine-1-carboxylate require standard laboratory precautions. While not classified as hazardous under normal conditions, it should be kept in a cool, dry environment, typically under inert atmosphere for long-term preservation. These practical considerations are frequently searched by laboratory technicians and synthetic chemists working with air-sensitive reagents.

The commercial availability of this compound through specialized chemical suppliers has expanded its accessibility to researchers worldwide. Current market trends show increasing demand for such high-purity synthetic intermediates, particularly from contract research organizations and academic institutions engaged in structure-activity relationship (SAR) studies. The compound's CAS No. 811439-53-9 serves as a crucial reference point for procurement and regulatory compliance across international markets.

Future research directions for tert-butyl 2-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine-1-carboxylate may explore its potential in emerging areas like bioorthogonal chemistry and theragnostic applications. The compound's dual functionality – the protected amine and the boronic ester – offers numerous possibilities for multi-component reactions and post-synthetic modifications. These aspects align with current scientific interests in precision medicine and personalized therapeutics, making it a compound worth watching in coming years.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)